Gentian Diagnostics AS (GENT) — Capital Reinvestment Ratio
Latest as of December 2025:
0.25x
Gentian Diagnostics AS (GENT) has a Capital Reinvestment Ratio of 0.25x as of December 2025, meaning it reinvests 0% of its operating cash flow (Nkr42.59 Million) in capital expenditures (Nkr10.76 Million). See how much free cash does Gentian Diagnostics AS generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.25x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr42.59 Million
NOK
Capital Expenditures
Nkr10.76 Million
NOK
Data as of
Dec 2025
Most recent filing
Gentian Diagnostics AS Capital Reinvestment Ratio (2013–2025)
This chart tracks Gentian Diagnostics AS's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Gentian Diagnostics AS (2013–2025)
Year-by-year Capital Reinvestment Ratio for Gentian Diagnostics AS from 2013 to 2025. For live market cap and broader valuation context, see how much is Gentian Diagnostics AS worth.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | Nkr42.59 Million | Nkr10.76 Million | ▼ -69.0% |
| 2024 | 0.81x | Nkr13.46 Million | Nkr10.95 Million | ▲ +180.3% |
| 2023 | 0.29x | Nkr15.46 Million | Nkr4.49 Million | ▼ -79.8% |
| 2013 | 1.44x | Nkr2.43 Million | Nkr3.49 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow